Summary
To investigate the mechanism of the relative beta-antagonist and agonist properties of pindolol, the cardiovascular effects of i.v. pindolol 0.01 mg/kg were studied in 23 subjects with different baseline levels of cardiac beta-adrenergic function. Baseline cardiac beta-adrenergic activity was assessed by the decrease in heart rate following intravenous propranolol 0.2 mg/kg (ΔHRβ) after parasympathetic blockade with intravenous atropine 0.04 mg/kg. Cardiac beta-adrenergic sensitivity was defined by the positive chronotropic effect of a three minute infusion of isoprenaline 0.005 µg/kg/min. The chronotropic effect of intravenous pindolol was negatively correlated with resting beta-adrenergic activity (R=−0.81, p<0.001). The traditional point of ΔHRβ, at which pindolol shifted from beta-antagonist to beta-agonist action, was 17 beats/min, i.e. pindolol decreased heart rate in subjects with ΔHRβ greater than 17 bpm, and increased heart rate in those with ΔHRβ less than 17 bpm. The chronotropic effect of intravenous pindolol, however, was positively correlated with beta-sensitivity (R=+0.73, p<0.001). Thus subjects with the greatest increment in heart rate with isoprenaline had an increased heart rate with pindolol, while those with the lowest increment in heart rate with isoprenaline had a decreased heart rate with pindolol. Intravenous pindolol decreased cardiac index and increased total peripheral resistance in the group with ΔHRβ more than 17 bpm, and it had the contrary actions in the group with ΔHRβ less than 17 bpm. Blood pressure in both groups was not significantly changed by pindolol. Compared to endogenous catecholamines, pindolol was considered to possess higher beta-adrenocepter affinity and weaker beta-adrenoceptor stimulating action. Therefore, pindolol produced a net beta-blocking action in subjects with elevated cardiovascular sympathetic nervous activity and beta-stimulating action in subjects with reduced sympathetic nervous activity.
Similar content being viewed by others
References
Prichard BNS, Gillam PMS (1969) Treatment of hypertension with propranolol. Br Med J 1: 7–16
Stokes GS, Weber MA, Thornell IR (1974) β-Blockers and plasma renin activity in hypertension. Br Med J 2: 60–62
Saxena P, Forsyth R (1976) Beta-adrenoceptor blocking agents. North-Holland, Amsterdam
Amsterdam EA, Gorlin R, Wolfson S (1969) Evaluation of longterm use of propranolol in angina pectoris. J Am Med Assoc 10: 103–107
Dollery CT, Paterson JW, Conolly ME (1969) Clinical pharmacology of beta-receptor blocking drugs. Clin Pharmacol Ther 10: 765–771
Barrett AM, Carter JW (1970) Comparative chronotropic activity of beta-adrenoceptor antagonists. Br J Pharmacol 40: 373–381
Samek L, Stürzenhofecker P, Roskamm H (1980) Pindolol bei Herzinfarkt-Patienten. Münch Med Wochenschr 122: 1071–1074
Reed JH, Wood EH (1967) Use of dichromatic earpiece densitometry for determination of cardiac output. J. Appl Physiol 23: 373–380
Robinson PS, Crowther A, Jenkins BS, Webb-Peploe MM, Coltart DJ (1979) A computerized dichromatic earpiece densitometer for the measurement of cardiac output. Cardiovasc Res 13: 420–426
DeQuattro V, Campese V, Miura Y, Meijer D (1976) Increased plasma catecholamines in high renin hypertension. Am J Cardiol 38: 801–804
Weidmann P, Hirsh D, Beretta-Piccoli C, Reubi FD, Ziegler WH (1977) Interrelations among blood pressure, blood volume, plasma renin activity and urinary catecholamines in benign essential hypertension. Am J Med 62: 209–218
Jose AD, Taylor RR (1969) Autonomic blockade by propranolol and atropine to study intrinsic myocardial function in man. J Clin Invest 48: 2019–2031
Julius S, Esler M (1975) Autonomic cardiovascular regulation in borderline hypertension. Am J Cardiol 36: 685–696
Tanaka N, Kudo A, Kawahira K (1977) A new method in the quantitative determination of the sympathetic nervous tone of the cardiovascular system in man. Proc 18th Intern Cong Neuroveg Res (Tokyo) p202–204
Coltart DJ, Gibson DG, Shand DG (1971) Plasma propranolol levels associated with suppression of ventricular ectopic beats. Br Med J 1: 490–494
Jingh BN, Jewitt DE (1974) β-Adrenergic receptor blocking drugs in cardiac arrhythmias. Drugs 7: 426–461
Neubauer B, Christensen NJ (1976) Norepinephrine, epinephrine and dopamine in long-term diabetics. Diabetes 25: 6–10
Jellinger K, Sturm W (1971) Delayed radiation myelopathy in man: report of twelve cases. J Neurol Sci 14: 389–408
O'Brien ET, Mackinnon J (1972) Propranolol and polythiazide in treatment of hypertension. Br Heart J 34: 1042–1044
Pape J (1974) The effect of alprenolol in combination with hydralazine in essential hypertension. Acta Med Scand 554: 55–62
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tanaka, N., Kawahira, K., Kudo, A. et al. Dependence of the cardiovascular effects of pindolol on the individual sympathetic nervous activity. Eur J Clin Pharmacol 22, 383–387 (1982). https://doi.org/10.1007/BF00542539
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00542539